The use of nanobiotechnological elements in the treatment of chronic pain was the center of the conversation of the Cedenna researchers in the internal seminar held on Thursday, November 26, with Dr. Luis Constandil, who wondered if after 10 years of designing , synthesizing and testing the efficacy of various nanoparticles for the treatment of chronic pain, it is possible to think about undertaking in this field to spread its benefits. Dr. Constandil explained the reasons why it has been difficult to advance in the commercialization of this type of elements and what paths we should follow in the future, to achieve real impacts on society.
- Log in to post comments
